Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Aripiprazole, and what generic Aripiprazole alternatives are available?

Aripiprazole is a drug marketed by Alembic Pharms Ltd, Amneal Pharms, Teva Pharms Usa, Aurobindo Pharma Ltd, Macleods Pharms Ltd, Torrent Pharms Ltd, Accord Hlthcare, Hetero Labs Ltd V, Silarx Pharms Inc, Ajanta Pharma Ltd, Stason Pharms, Apotex Inc, and Sciegen Pharms Inc. and is included in eighteen NDAs.

The generic ingredient in ARIPIPRAZOLE is aripiprazole. There are forty-four drug master file entries for this compound. Forty suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the aripiprazole profile page.

Summary for Tradename: ARIPIPRAZOLE

Suppliers / Packagers: see list29
Bulk Api Vendors: see list94
Clinical Trials: see list77
Patent Applications: see list3,065
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARIPIPRAZOLE at DailyMed

Pharmacology for Tradename: ARIPIPRAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc
TABLET;ORAL206383-002Sep 29, 2016ABRXNoNo► Subscribe► Subscribe
Accord Hlthcare
TABLET;ORAL206251-002Dec 7, 2016ABRXNoNo► Subscribe► Subscribe
Torrent Pharms Ltd
TABLET;ORAL201519-005Apr 28, 2015ABRXNoNo► Subscribe► Subscribe
Hetero Labs Ltd V
TABLET;ORAL205064-004Apr 28, 2015ABRXNoNo► Subscribe► Subscribe
Stason Pharms
TABLET;ORAL091279-002Jan 9, 2017ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus